A COVID-19 collaboration as big as Texas

The COVID-19 Drug Discovery Consortium, an international team of computational scientists, medicinal chemists, biochemists, and virologists have come together quickly to identify drug-like molecules that inhibit SARS-CoV-2 replication. “We are uniquely positioned for this,” said UTMB’s Stan Watowich. “We’ve done it for a long time. We know lots of players.”